Growth Metrics

Repligen (RGEN) Equity Ratio (2016 - 2025)

Repligen (RGEN) has disclosed Equity Ratio for 15 consecutive years, with 0.71 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 2.42% to 0.71 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.71, a 2.42% increase, with the full-year FY2025 number at 0.71, up 2.42% from a year prior.
  • Equity Ratio was 0.71 for Q4 2025 at Repligen, roughly flat from 0.71 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.81 in Q1 2021 to a low of 0.69 in Q1 2024.
  • A 5-year average of 0.74 and a median of 0.74 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: grew 6.16% in 2021, then fell 9.52% in 2024.
  • Repligen's Equity Ratio stood at 0.74 in 2021, then grew by 1.71% to 0.75 in 2022, then fell by 8.05% to 0.69 in 2023, then grew by 0.45% to 0.7 in 2024, then rose by 2.42% to 0.71 in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Equity Ratio are 0.71 (Q4 2025), 0.71 (Q3 2025), and 0.71 (Q2 2025).